Health News Releases

March 15, 2021 12:00

Landmark Long-Term Data from EORTC’s MINDACT Study Published in The Lancet Oncology

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that long-term follow up data from MINDACT, the prospective, randomized trial designed to further confirm the cli

March 12, 2021 18:55

Takeda’s Growth and Emerging Markets Business Unit Aims to Deliver Double-Digit Revenue Growth Over Next Decade[1]

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today outlined its ambition for above-market, double-digit revenue growth of its Growth and Emerging Markets Business Unit (“GEM BU

March 12, 2021 17:10

Humanigen Announces $80 Million Loan Facility from Hercules Capital

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat

March 12, 2021 17:07

Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for Hereditary Angioedema Attacks

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) in Japan fo

March 12, 2021 15:05

Humanigen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat

March 11, 2021 19:40

Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the exercise of its option to acquire Maverick Therapeutics, Inc. a private biopharmaceutical company pioneering co

March 11, 2021 17:30

Korea’s Ministry of Health and Welfare and KHIDI Announce Medical Korea 2021 Virtual Conference: “Global Healthcare, Where Your Days Begin Again”

The upcoming Medical Korea 2021, the 11th Global Healthcare and Medical Tourism Conference, is being held virtually to discuss the latest healthcare trends and forecasts, to share Korea’s advancing me

March 10, 2021 13:55

Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19

Tanner Pharma Group (Tanner) today announced expansion of the LEUKINE Access Program (LeAP) as a channel for distribution of LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the

March 10, 2021 11:20

Covetrus Announces Vice President of Global Talent Management

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the addition of Stacey M.M. Shirra as vice president of global talent management. The newly created p

March 09, 2021 18:55

Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform

Regenerative therapy to treat knee joint damages gets a boost with a breakthrough technology of growing ideal type of cartilage cells including chondroprogenitors and mesenchymal stem cells enriched w

March 09, 2021 17:25

Masimo Monitoring Solutions Promote Newborn and Maternal Safety

Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET® pulse

March 08, 2021 15:37

Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

Regulatory News: Vifor Pharma and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the New Drug A

March 08, 2021 13:10

TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round

TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and

March 08, 2021 11:20

Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform th

March 08, 2021 09:40

LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes

Veeva Systems (NYSE: VEEV) announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault

March 05, 2021 14:50

COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement From Japan

ß- glucan produced by AFO-202 strain of black yeast Aureobasidium Pullulans (Nichi Glucan), having immune enhancement potentials through all major pathways, has been recommended worth clinical studies

March 04, 2021 19:15

PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer

PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforc

March 04, 2021 17:58

Galderma Continues Global Growth Ambition With Sculptra® (injectable poly-L-lactic Acid) Re-launch in Europe

Galderma today announced a European re-launch of Sculptra® (injectable poly-L-lactic acid) - a collagen stimulator - with an updated administration protocol. This means that the product is ready for u

March 03, 2021 18:45

Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth[1]

Regulatory News: Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much s

March 03, 2021 18:05

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies

New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in

March 03, 2021 17:20

Masimo Announces CE Marking of the Rad-G™ with Temperature

Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET® pulse oximetry, respiration rate from the pleth (RRp®

March 03, 2021 11:00

ALPINION Launches A High-Performance Ultrasound Diagnostic System ‘X-CUBE 90’

ALPINION MEDICAL SYSTEMS Co., Ltd (ALPINION), a medical ultrasound professional, announced that it will launch X-CUBE 90 in March. X-CUBE 90 is the top-tier model of X-CUBE, a brand developed by up

March 03, 2021 08:50

Theramex Launches New Website

Theramex, a global company specialised in women‘s health, has launched a new website. It is a modern, intuitive and easy-to-navigate site that seeks to position itself as a benchmark for information o

March 02, 2021 21:00

Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited

Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to transfer the assets, marketing rights and, eventually, marketing autho

March 02, 2021 17:50

Illuminating the Heroes of Rare Diseases

With a mission of empowering the rare disease community, Illumina has today partnered with medical researchers and families to highlight the importance of genomic sequencing and to shine the spotlight

News by Region

News by Industry